Effect of blood donor characteristics on transfusion outcomes: A protocol for systematic review and meta-analysis

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Chassé, Michaël ^a   English, Shane W ^a   McIntyre, Lauralyn ^a   Knoll, Greg ^a   Shehata, Nadine ^b   Forster, Alan ^c   Wilson, Kumanan ^d   van Walraven, Carl ^a   Tinmouth, Alan ^a   Fergusson, Dean A ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL PRACTICE; ERYTHROCYTE; GENETIC HETEROGENEITY; HEALTH CARE POLICY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; SYSTEMATIC REVIEW; ERYTHROCYTE TRANSFUSION; REVIEW; STATISTICS; TREATMENT OUTCOME;

BLOOD DONORS; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; HUMANS; TREATMENT OUTCOME;

EID: 84907274425     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-28     Document Type: Article

References (19)

1. Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet 2007, 370:415-426. 10.1016/S0140-6736(07)61197-0, 17679019.
2. Raghavan M, Marik PE. Anemia, allogenic blood transfusion, and immunomodulation in the critically ill. Chest 2005, 127:295-307. 10.1378/chest.127.1.295, 15653997.
3. Bennett-Guerrero E, Zhao Y, O'Brien SM, Ferguson TB, Peterson ED, Gammie JS, Song HK. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA 2010, 304:1568-1575. 10.1001/jama.2010.1406, 20940382.
4. Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology 2011, 115:635-649. 10.1097/ALN.0b013e31822a22d9, 3162102, 21792054.
5. Vamvakas EC, Blajchman M. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Blood 2009, 113:3406-3417. 10.1182/blood-2008-10-167643, 19188662.
6. O'Brien SF, Yi Q-L, Fan W, Scalia V, Fearon MA, Allain J-P. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang 2012, 103:83-86. 10.1111/j.1423-0410.2012.01584.x, 22289147.
7. Toy P, Gajic O, Bacchetti P, Looney MR, Gropper MA, Hubmayr R, Lowell CA, Norris PJ, Murphy EL, Weiskopf RB, Wilson G, Koenigsberg M, Lee D, Schuller R, Wu P, Grimes P, Gandhi MJ, Winters JL, Mair D, Hirschler N, Sanchez Rosen R, Mattay MA. Transfusion-related acute lung injury: incidence and risk factors. Blood 2012, 119:1757-1767. 10.1182/blood-2011-08-370932, 3286351, 22117051.
8. Chapman CE, Williamson LM. National Blood Service TRALI reduction policies: implementation and effect. Transfus Med Hemother 2008, 35:93-96. 10.1159/000119116, 3076341, 21512634.
9. Taylor DO, Stehlik J, Edwards LB, Aurora P, Christie JD, Dobbels F, Kirk R, Kucheryavaya AY, Rahmel AO, Hertz MI. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 2009, 28:1007-1022. 10.1016/j.healun.2009.08.014, 19782283.
10. Lee K-W, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation 2006, 82:1683-1688. 10.1097/01.tp.0000250936.73034.98, 17198260.
11. Akkina SK, Asrani SK, Peng Y, Stock P, Kim WR, Israni AK. Development of organ-specific donor risk indices. Liver Transpl 2012, 18:395-404. 10.1002/lt.23398, 3332103, 22287036.
12. Maglione M, Ploeg RJ, Friend PJ. Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation. Curr Opin Organ Transplant 2013, 18:83-88. 10.1097/MOT.0b013e32835c29ef, 23254698.
13. Kollman C, Howe CW, Anasetti C, Antin JH, Davies SM, Filipovich AH, Hegland J, Kamani N, Kernan NA, King R, Ratanatharathorn V, Wiesdorf D, Confer DL. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2043-2051, 2001:98.
14. Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011, 51:1716-1722. 10.1111/j.1537-2995.2010.03009.x, 3137746, 21214586.
15. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011, Chichester, UK: John Wiley & Sons Ltd.
16. Reeves BC, Deeks JJ, Higgins JP, Wells GA. Chapter 13: Including non-randomized studies. Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). The Cochrane Collaboration 2011, Chichester, UK: John Wiley & Sons Ltd, Higgins JPT, Green S.
17. Zeiler T, Lander-Kox J, Eichler H, Alt T, Bux J. The safety of blood donation by elderly blood donors. Vox Sang 2011, 101:313-319. 10.1111/j.1423-0410.2011.01492.x, 21535439.
18. Eder A, Goldman M, Rossmann S, Waxman D, Bianco C. Selection criteria to protect the blood donor in North America and Europe: past (dogma), present (evidence), and future (hemovigilance). Transfus Med Rev 2009, 23:205-220. 10.1016/j.tmrv.2009.03.003, 19539875.
19. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336:924-926. 10.1136/bmj.39489.470347.AD, 2335261, 18436948.